Inoperable/metastatic well-differentiated (grade 1/2) NET |
Well-differentiated grade 3 NET may be considered (further data are required on response rates and survival in this newly defined subgroup) |
Sufficient tumor uptake on the diagnostic somatostatin receptor-based imaging |
Sufficient bone marrow reserves (grades 1 to 2 haematological toxicity usually accepted) |
Creatinine clearance >50 mL/min |
Karnofsky performance status >50 |
Expected survival >3 months |
Signed informed consent |
Do you want to add Medilib to your home screen?